Cargando…

Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups

OBJECTIVE: Mechanisms driving temporal fluctuations of inflammatory markers during pregnancy, and how these might differ between distinct perinatal depressive trajectories, are not well understood. The aim of this study was to investigate cytokines levels over the course of pregnancy in women with d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bränn, Emma, Skalkidou, Alkistis, Schwarz, Jaclyn, Papadopoulos, Fotios C., Sundström Poromaa, Inger, Fransson, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097612/
https://www.ncbi.nlm.nih.gov/pubmed/35571146
http://dx.doi.org/10.1016/j.bbih.2022.100468
_version_ 1784706213537120256
author Bränn, Emma
Skalkidou, Alkistis
Schwarz, Jaclyn
Papadopoulos, Fotios C.
Sundström Poromaa, Inger
Fransson, Emma
author_facet Bränn, Emma
Skalkidou, Alkistis
Schwarz, Jaclyn
Papadopoulos, Fotios C.
Sundström Poromaa, Inger
Fransson, Emma
author_sort Bränn, Emma
collection PubMed
description OBJECTIVE: Mechanisms driving temporal fluctuations of inflammatory markers during pregnancy, and how these might differ between distinct perinatal depressive trajectories, are not well understood. The aim of this study was to investigate cytokines levels over the course of pregnancy in women with different trajectories of depressive symptoms peripartum, and relate the levels to levels of non-pregnant controls. METHODS: Based on the Edinburgh Postnatal Depression Scale and/or selective serotonin reuptake inhibitors use, 131 women were categorized into: no (n = 65); antepartum (APD, n = 19), postpartum (PPD, n = 17) and persistent (n = 30) depressive symptoms. Plasma samples (n = 386) were analyzed for levels of interleukin (IL)-8, IL-18, Tumor necrosis factor-α, macrophage colony-stimulating factor (M-CSF), vascular endothelial growth factor A (VEGF-A) and fractalkine, at four different time-points (twice during pregnancy, during childbirth, and postpartum) using Bio-Plex Pro Human Cytokine Assays. Generalized linear mixed models were applied to analyze the associations between cytokine levels, time-point, perinatal depressive symptom trajectory group and their interaction. RESULTS: For all markers but VEGF-A, pregnancy was associated with higher cytokine levels compared to the non-pregnant controls, with delivery being the most prominent time-point. For M-CSF, IL-18 and VEGF-A, levels were back to the non-pregnant status at postpartum week 8. An effect of perinatal depressive symptom trajectory groups on cytokine levels was found for VEGF-A. Women with PPD and women with APD had lower levels of VEGF-A throughout the study period compared to women with persistent depression, and women with PPD had lower levels compared to non-depressed women. CONCLUSIONS: Lower levels of VEGF-A were noted among women in some trajectories of depressive symptoms peripartum. The peripartum period is a time of tremendous immune system adaptations. Standardization of time-points for cytokine measurements in studies of perinatal depression are important in order to draw valid conclusions on the role of the immune system in perinatal depression.
format Online
Article
Text
id pubmed-9097612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-90976122022-05-13 Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups Bränn, Emma Skalkidou, Alkistis Schwarz, Jaclyn Papadopoulos, Fotios C. Sundström Poromaa, Inger Fransson, Emma Brain Behav Immun Health Full Length Article OBJECTIVE: Mechanisms driving temporal fluctuations of inflammatory markers during pregnancy, and how these might differ between distinct perinatal depressive trajectories, are not well understood. The aim of this study was to investigate cytokines levels over the course of pregnancy in women with different trajectories of depressive symptoms peripartum, and relate the levels to levels of non-pregnant controls. METHODS: Based on the Edinburgh Postnatal Depression Scale and/or selective serotonin reuptake inhibitors use, 131 women were categorized into: no (n = 65); antepartum (APD, n = 19), postpartum (PPD, n = 17) and persistent (n = 30) depressive symptoms. Plasma samples (n = 386) were analyzed for levels of interleukin (IL)-8, IL-18, Tumor necrosis factor-α, macrophage colony-stimulating factor (M-CSF), vascular endothelial growth factor A (VEGF-A) and fractalkine, at four different time-points (twice during pregnancy, during childbirth, and postpartum) using Bio-Plex Pro Human Cytokine Assays. Generalized linear mixed models were applied to analyze the associations between cytokine levels, time-point, perinatal depressive symptom trajectory group and their interaction. RESULTS: For all markers but VEGF-A, pregnancy was associated with higher cytokine levels compared to the non-pregnant controls, with delivery being the most prominent time-point. For M-CSF, IL-18 and VEGF-A, levels were back to the non-pregnant status at postpartum week 8. An effect of perinatal depressive symptom trajectory groups on cytokine levels was found for VEGF-A. Women with PPD and women with APD had lower levels of VEGF-A throughout the study period compared to women with persistent depression, and women with PPD had lower levels compared to non-depressed women. CONCLUSIONS: Lower levels of VEGF-A were noted among women in some trajectories of depressive symptoms peripartum. The peripartum period is a time of tremendous immune system adaptations. Standardization of time-points for cytokine measurements in studies of perinatal depression are important in order to draw valid conclusions on the role of the immune system in perinatal depression. Elsevier 2022-05-02 /pmc/articles/PMC9097612/ /pubmed/35571146 http://dx.doi.org/10.1016/j.bbih.2022.100468 Text en © 2022 The Authors. Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Full Length Article
Bränn, Emma
Skalkidou, Alkistis
Schwarz, Jaclyn
Papadopoulos, Fotios C.
Sundström Poromaa, Inger
Fransson, Emma
Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title_full Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title_fullStr Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title_full_unstemmed Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title_short Longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
title_sort longitudinal assessment of inflammatory markers in the peripartum period by depressive symptom trajectory groups
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097612/
https://www.ncbi.nlm.nih.gov/pubmed/35571146
http://dx.doi.org/10.1016/j.bbih.2022.100468
work_keys_str_mv AT brannemma longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups
AT skalkidoualkistis longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups
AT schwarzjaclyn longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups
AT papadopoulosfotiosc longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups
AT sundstromporomaainger longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups
AT franssonemma longitudinalassessmentofinflammatorymarkersintheperipartumperiodbydepressivesymptomtrajectorygroups